Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-25-063972
Filing Date
2025-05-06
Accepted
2025-05-06 07:45:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 424b3_okur_q1_2025_10-q_.htm 424B3 2367150
2 GRAPHIC img25913967_0.jpg GRAPHIC 9503
  Complete submission text file 0000950170-25-063972.txt   2381496
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282792 | Film No.: 25915279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)